CEFEPIME HYDROCHLORIDE; ZIDEBACTAM | N220787 | WOCKHARDT BIO AG
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8822450Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Aug 24, 2032 | — | Yes | Yes | — | — |
| 8853197Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Aug 24, 2032 | — | Yes | — | — | — |
| 9132133Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Aug 24, 2032 | — | — | — | — | |
| 9381200Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Aug 24, 2032 | — | — | Yes | — | — |
| 9657021Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Oct 12, 2033 | — | Yes | — | — | — |
| 9827235Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Aug 24, 2032 | — | — | Yes | — | |
| 9834557Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Oct 12, 2033 | — | Yes | — | — | — |
| Code | Date | Status |
|---|---|---|
| NCENewly listed — daily FDA feed, not yet in monthly Orange Book edition | May 29, 2031 | Active |
| NCE*GAINNewly listed — daily FDA feed, not yet in monthly Orange Book edition | May 29, 2036 | Active |
Wockhardt Bio AG's ZAYNICH (cefepime hydrochloride; zidebactam) received new chemical entity exclusivity expiring May 2031.
New: ZAYNICH (CEFEPIME HYDROCHLORIDE; ZIDEBACTAM) — exclusivity NCE exp 05/29/2031
Zaynich (cefepime hydrochloride; zidebactam) received new chemical entity exclusivity with expiration in May 2036.
New: ZAYNICH (CEFEPIME HYDROCHLORIDE; ZIDEBACTAM) — exclusivity NCE*GAIN exp 05/29/2036